kidney disease glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Real-World Evidence for GLP-1 Receptor
Description
Discover the trends impacting CPG brands, foodservice, product innovation, and menu development.
Cigna will stop covering GLP-1 weight-loss drugs such as Wegovy and Zepbound for its employees starting July 1, signaling that even major healthcare companies are struggling with the high cost of these medications
"The Office" actor is among the celebrities people are speculating use Ozempic, a brand name of the weight loss and diabetes drug semaglutide.
A KFYR+ exclusive
My clothes fit again, no more muffin top
Lawsuits are piling up against makers of Ozempic, Wegovy and Mounjaro, with patients alleging blindness, bowel injuries and brain damage
